Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin. - Concepedia

Concepedia

Publication | Closed Access

Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin.

20

Citations

0

References

2001

Year

S Boncinelli, M Marsili, P Lorenzi, L P Fabbri, S Pittino, M Filoni, Fabiana Fernandes Bressan, Elena Sarti, S. Cinotti, M. Morfini

Abstract

These results prove that a single daily dose of nadroparin has been safe and efficient as a thrice-daily dose of UFH, with a better risk/benefit relationship.